US$ 26.88
5-amino-1mq purity (5-Amino-1-Methylquinolinium Chloride) – 98%+ – 5g 5-AMINO-1MQ PEPTIDE 50MG/100MG VIAL (10-PACK)
Description
Mild headache or dizziness : This normally passes quickly

Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs

Has no effect on insulin or blood sugar

Verifiable Batch Testing: Every batch of our CJC/Ipamorelin blends and specialty compounds is third-party tested to guarantee purity thresholds exceed 99%
